FAKTOR-OPTIONSSCHEIN - MIMEDX GROUP Stock

Certificat

DE000MG23S35

Market Closed - Börse Stuttgart 02:53:17 2024-07-16 pm EDT
10.5 EUR +8.14% Intraday chart for FAKTOR-OPTIONSSCHEIN - MIMEDX GROUP
Current month+11.11%
1 month+14.01%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 10.5 +8.14%
24-07-15 9.71 -1.32%
24-07-12 9.84 +0.20%
24-07-11 9.82 +8.03%
24-07-10 9.09 +0.44%

Delayed Quote Börse Stuttgart

Last update July 16, 2024 at 02:53 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MIMEDX GROUP, INC.
Issuer Morgan Stanley
WKN MG23S3
ISINDE000MG23S35
Date issued 2024-04-10
Strike 3.741 $
Maturity Unlimited
Parity 0.32 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.07
Lowest since issue 6.9
Spread 0.07
Spread %0.65%

Company Profile

MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
Sector
-
More about the company

Ratings for MiMedx Group, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: MiMedx Group, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
7.48 USD
Average target price
12.44 USD
Spread / Average Target
+66.35%
Consensus